MUC1 and idiopathic pulmonary fibrosis: Pioneering studies before the “antifibrotic era” found that in patients with IPF, an elevated baseline blood level of mucin-1/KL-6 was associated with a greater decline in FVC [46], reduced survival [33,46], and an enhanced risk of AE-IPF [34].